Affective Prodromes of Medical Illness

Fava, Giovanni A.; Morphy, Murray A.; Sonino, Nicoletta

doi:10.1159/000288916

Cited by 9 publications

(14 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Lishman [74] outlined the range of problems which may be associated with silent or mild cerebrovascular disorders (including hypochondriasis and bodily preoccupations) and may be prodromal to cognitive deterioration. Indeed, depression, anxiety, irritability and somatic symptoms are often prodromes of a medical disorder [74, 75]. Not surprisingly, psychological assessment with DCPR was found to be more suitable than DSM-IV criteria in identifying somatization in patients with functional gastrointestinal disturbances or cardiac disease [76].…”

Section: Expanding the Spectrum Of Psychosocial Assessmentmentioning

confidence: 99%

Psychosomatic Assessment

Fava

Sonino²

2009

Psychother Psychosom

Self Cite

View full text Add to dashboard Cite

The primary goal of psychosomatic medicine is the incorporation of its operational strategies into clinical practice. The traditional attitude toward disease and the functional/organic dichotomy were criticized by George Engel in the early sixties. Only recently, however, there has been increasing awareness of the limitations of disease as the primary focus of medical care. It is not that certain disorders lack an organic explanation; it is our assessment that is inadequate in most clinical encounters. The research evidence which has accumulated in psychosomatic medicine offers unprecedented opportunities for the identification and treatment of medical problems. Taking full advantage of clinimetric methods (such as the use of Emmelkamp’s two levels of functional analysis and the Diagnostic Criteria for Psychosomatic Research) may greatly improve the clinical process, including shared decision making and self-management. Endorsement of the psychosomatic perspective may better clarify the pathophysiological links and mechanisms underlying symptom presentation. Pointing to individually targeted methods may improve final outcomes and quality of life.

show abstract

Section: Expanding the Spectrum Of Psychosocial Assessmentmentioning

confidence: 99%

Psychosomatic Assessment

Fava

Sonino²

2009

Psychother Psychosom

Self Cite

View full text Add to dashboard Cite

show abstract

“…Important psychiatric morbidity was consistently reported in the endocrine illnesses listed in Table 1. At times, such symptoms may precede other manifestations of an endocrine disorder and/or be early indicators of its relapse (Fava et al, 1994).…”

Section: Psychiatric Disturbancesmentioning

confidence: 99%

“…The occurrence of mania, a distinct period of abnormally and persistently elevated and expansive mood (with symptoms such as grandiosity, decreased need to sleep, distractibility, increase in goal directed activity, excessive involvement in pleasurable activities, pressure to keep talking and flight of ideas), is much less frequent than that of depression in the medically ill (Fava et al, 1994). In Cushing's syndrome, manic or hypomanic symptoms may however, take place and be among the early manifestations of illness (Fava et al, 1994).…”

Section: Maniamentioning

confidence: 99%

See 1 more Smart Citation

Psychological aspects of endocrine disease

Sonino

Fava

1998

Clinical Endocrinology

Self Cite

View full text Add to dashboard Cite

“…Up to 80% of patients have generalised anxiety and 70% have major depression (42). Although not as common, manic or hypomanic symptoms may occur and be among the early manifestations of the disease (43).…”

Section: Patients With Active Csmentioning

confidence: 99%

MANAGEMENT OF ENDOCRINE DISEASE: Cushing's syndrome: a structured short- and long-term management plan for patients in remission

Ragnarsson

Johannsson

2013

European Journal of Endocrinology

View full text Add to dashboard Cite

One hundred years have passed since Harvey Williams Cushing presented the first patient with the syndrome that bears his name. In patients with Cushing's syndrome (CS), body composition and lipid, carbohydrate and protein metabolism are dramatically affected and psychopathology and cognitive dysfunction are frequently observed. Untreated patients with CS have a grave prognosis with an estimated 5-year survival of only 50%. Remission can be achieved by surgery, radiotherapy and sometimes with medical therapy. Recent data indicate that the adverse metabolic consequences of CS are present for years after successful treatment. In addition, recent studies have demonstrated that health-related quality of life and cognitive function are impaired in patients with CS in long-term remission. The focus of specialised care should therefore be not only on the diagnostic work-up and the early postoperative management but also on the long-term follow-up. In this paper, we review the long-term consequences in patients with CS in remission with focus on the neuropsychological effects and discuss the importance of these findings for long-term management. We also discuss three different phases in the postoperative management of surgically-treated patients with CS, each phase distinguished by specific challenges: the immediate postoperative phase, the glucocorticoid dose tapering phase and the long-term management. The focus of the long-term specialised care should be to identify cognitive impairments and psychiatric disorders, evaluate cardiovascular risk, follow pituitary function and detect possible recurrence of CS.

show abstract

Affective Prodromes of Medical Illness

Cited by 9 publications

References 16 publications

Psychosomatic Assessment

Psychosomatic Assessment

Psychological aspects of endocrine disease

MANAGEMENT OF ENDOCRINE DISEASE: Cushing's syndrome: a structured short- and long-term management plan for patients in remission

Contact Info

Product

Resources

About